Candriam SCA’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-509,000
| Closed | -$3.38M | – | 818 |
|
|
2018
Q4 | $3.38M | Hold |
509,000
| – | – | 0.05% | 356 |
|
|
2018
Q3 | $5.43M | Buy |
509,000
+137,000
| +37% | +$1.46M | 0.07% | 297 |
|
|
2018
Q2 | $4.46M | Buy |
372,000
+104,000
| +39% | +$1.25M | 0.07% | 317 |
|
|
2018
Q1 | $2.3M | Hold |
268,000
| – | – | 0.04% | 450 |
|
|
2017
Q4 | $2.65M | Sell |
268,000
-25,000
| -9% | -$247K | 0.05% | 400 |
|
|
2017
Q3 | $3.6M | Hold |
293,000
| – | – | 0.06% | 336 |
|
|
2017
Q2 | $4.82M | Buy |
293,000
+33,000
| +13% | +$543K | 0.09% | 269 |
|
|
2017
Q1 | $3.73M | Buy |
260,000
+65,000
| +33% | +$932K | 0.07% | 316 |
|
|
2016
Q4 | $2.7M | Hold |
195,000
| – | – | 0.06% | 312 |
|
|
2016
Q3 | $3.52M | Buy |
195,000
+67,000
| +52% | +$1.21M | 0.08% | 255 |
|
|
2016
Q2 | $1.84M | Sell |
128,000
-25,000
| -16% | -$359K | 0.05% | 327 |
|
|
2016
Q1 | $1.82M | Sell |
153,000
-12,000
| -7% | -$143K | 0.05% | 336 |
|
|
2015
Q4 | $2.2M | Buy |
+165,000
| New | +$2.2M | 0.06% | 283 |
|
|
2015
Q2 | – | Sell |
-81,429
| Closed | -$538K | – | 653 |
|
|
2015
Q1 | $538K | Hold |
81,429
| – | – | 0.01% | 535 |
|
|
2014
Q4 | $519K | Buy |
+81,429
| New | +$519K | 0.01% | 517 |
|